Understanding Ketamine Treatments with Dr. Banimahd

In this episode of the Addict to Athlete podcast, Coach Blu Robinson welcomes Dr. Faried Banimahd to discuss the complexities of ketamine therapy in the context of mental health and addiction recovery. They explore the history of ketamine, its medical uses, particularly in pain management and mental health treatment, and the implications of its recent popularity as a therapeutic option. Dr. B provides insights into the mechanisms of ketamine, its FDA approval for treatment-resistant depression, and the importance of caution in its use, especially for individuals with a history of substance abuse. The conversation emphasizes the need for a comprehensive approach to mental health treatment, integrating therapy with any pharmacological interventions. In this conversation, Blu Robinson and Dr. Faried Banimahd delve into the complexities of psychedelics, particularly ketamine, and their potential therapeutic benefits for mental health. They discuss the risks associated with psychedelics, personal experiences, and the importance of controlled environments for treatment. The conversation also highlights the stigma surrounding these substances, the necessity of ongoing treatment, and the role of medical professionals in guiding patients through their mental health journeys. Ultimately, they emphasize the need for a multidimensional approach to treatment and the importance of understanding individual experiences within the broader healthcare system.

Follow Dr. B YouTube · Dr.B36087.1K+ followersDr.B360

insta Instagram · getdrb2.4K+ followersAddiction Medicine (@getdrb) • Instagram photos and videos

Takeaways

• Ketamine is chemically related to PCP and has a history of abuse.
• It is used as a disassociative anesthetic in medical settings.
• Ketamine's role in pain management is significant, especially for chronic pain patients.
• The FDA has approved ketamine for treatment-resistant depression under specific protocols.
• Ketamine works by blocking NMDA receptors, affecting pain perception and mood.
• Long-term efficacy of ketamine therapy is still under research and not well established.
• Caution is advised for individuals with a history of substance abuse when considering ketamine therapy.
• Matthew Perry's case highlights the risks associated with unsupervised ketamine use.
• Therapy should be the first line of treatment for depression, even when using ketamine.
• Meaningful existence and self-development take time and should not be rushed. People with a history of severe bipolar and schi